DrugDashboards

Xeloda

capecitabine · CAPECITABINE 500 mg/1 · Tablet, Film Coated · Oral · H2-Pharma, LLC

NDC 61269-0475-12 · 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC · NDA · View full market →

The short version

17 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$2.99per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal ceiling (Big4)$34.84per unitH2-Pharma, LLC · Jan 1, 2026
  • Medicaid generic ceiling (FUL)$0.5571per TABweighted avg manufacturer price $0.3183 · Aug 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$5,422.31
Reported to Texas DSHS · 2026 annual filing · H2-Pharma, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$1.4M
395 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for capecitabine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA020896
TE code
—
Approval date
Apr 30, 1998
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of capecitabine (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
BluePoint LaboratoriesCAPECITABINE 500 mg/1Jul 15, 2026Sep 3, 2026
BluePoint LaboratoriesCAPECITABINE 150 mg/1Jul 15, 2026Sep 3, 2026
Accord Healthcare Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Excella GmbH & Co. KGCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma, LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Teyro Labs Private LimitedCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teyro Labs Private LimitedCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Xeloda — NDC 61269-0475-12," retrieved September 3, 2026, https://drugdashboards.com/drug/61269047512.

Free to cite with attribution — see how the data is put together.